Track the Suzhou Ribo Life Science Co., Ltd. - B - H Shares share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Market capitalisation: €40.7bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: GAN LIMING. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
苏州瑞博生物技术有限公司是一家专注于健康产品开发的生物技术公司。该公司以H股形式在香港证券交易所上市。